Chemotherapy induced nausea and vomiting
Chemotherapy Induced Nausea and Vomiting
Grand Canyon University
Introduction to Nursing Research
NRS-433V
Debbie Beck July 14, 2014
Chemotherapy Induced Nausea and Vomiting
The article that I choose for this assignment will review the interventions and prevention of chemotherapy induced nausea and vomiting. Unfortunately nausea and vomiting are one of the unexpected result of chemotherapy that can affect the physiological and psychological wellbeing of a cancer patient. This distressing side effect can be dose reducing or possibly severe enough to discontinue therapy. There have been significant progress in the handling of nausea and vomiting. This article will examine present pharmacological and nonpharmacological interventions for reducing chemotherapy induced nausea and vomiting. Nausea and vomiting is a tormenting side effect that a patient can encounter during their cancer treatment. Research has documented that the incidence of acute and delayed post chemotherapy nausea and vomiting is greater than 50%, even after antiemetic prophylaxis (Janelle M. Tipton, 2007). The ultimate outcome of intervention is the prevention and management of this distressing side effect. Also to promote a sence wellness and have a quality of life for the patient and their families. Studies were done on mature patients who were receiving chemotherapy due to a cancer diagnosis. The study looked at patients who had pharmacological intervention, nonpharmacological intervertion and a combination of both. The use of non pharmacological intervention alone without use of as 5-HT receptor antagonist lacked the emperical or quanative evidence to recommend for practice. Pharmacological interventions include 5-HT receptor antagonist such as Aloxi, Zofran, Kytril, dexamethasone are recommended for treatment as well as lorazapam and benzodiazapine for anticipatory nausea and vomiting. Several
Grand Canyon University
Introduction to Nursing Research
NRS-433V
Debbie Beck July 14, 2014
Chemotherapy Induced Nausea and Vomiting
The article that I choose for this assignment will review the interventions and prevention of chemotherapy induced nausea and vomiting. Unfortunately nausea and vomiting are one of the unexpected result of chemotherapy that can affect the physiological and psychological wellbeing of a cancer patient. This distressing side effect can be dose reducing or possibly severe enough to discontinue therapy. There have been significant progress in the handling of nausea and vomiting. This article will examine present pharmacological and nonpharmacological interventions for reducing chemotherapy induced nausea and vomiting. Nausea and vomiting is a tormenting side effect that a patient can encounter during their cancer treatment. Research has documented that the incidence of acute and delayed post chemotherapy nausea and vomiting is greater than 50%, even after antiemetic prophylaxis (Janelle M. Tipton, 2007). The ultimate outcome of intervention is the prevention and management of this distressing side effect. Also to promote a sence wellness and have a quality of life for the patient and their families. Studies were done on mature patients who were receiving chemotherapy due to a cancer diagnosis. The study looked at patients who had pharmacological intervention, nonpharmacological intervertion and a combination of both. The use of non pharmacological intervention alone without use of as 5-HT receptor antagonist lacked the emperical or quanative evidence to recommend for practice. Pharmacological interventions include 5-HT receptor antagonist such as Aloxi, Zofran, Kytril, dexamethasone are recommended for treatment as well as lorazapam and benzodiazapine for anticipatory nausea and vomiting. Several